These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 23025763

  • 1. Physiopathology of intrauterine growth retardation: from classic data to metabolomics.
    Dessì A, Ottonello G, Fanos V.
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):13-8. PubMed ID: 23025763
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Foetal programming of nutrition-related chronic diseases].
    Delisle H.
    Sante; 2002 Oct; 12(1):56-63. PubMed ID: 11943639
    [Abstract] [Full Text] [Related]

  • 4. Maternal risk factors for low birth weight and intrauterine growth retardation in a Guatemalan population.
    Neel NR, Alvarez JO.
    Bull Pan Am Health Organ; 1991 Oct; 25(2):152-65. PubMed ID: 1893240
    [Abstract] [Full Text] [Related]

  • 5. [Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].
    Vega J, Sáez G, Smith M, Agurto M, Morris NM.
    Rev Med Chil; 1993 Oct; 121(10):1210-9. PubMed ID: 8191127
    [Abstract] [Full Text] [Related]

  • 6. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome.
    Dessì A, Atzori L, Noto A, Visser GH, Gazzolo D, Zanardo V, Barberini L, Puddu M, Ottonello G, Atzei A, De Magistris A, Lussu M, Murgia F, Fanos V.
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():35-9. PubMed ID: 21767100
    [Abstract] [Full Text] [Related]

  • 7. Fetal development and risk of cardiovascular diseases and diabetes type 2 in adult life.
    Szostak-Węgierek D, Szamotulska K.
    Med Wieku Rozwoj; 2011 Oct; 15(3):203-15. PubMed ID: 22006475
    [Abstract] [Full Text] [Related]

  • 8. Severe intrauterine growth restriction is associated with higher spontaneous carbohydrate intake in young women.
    Barbieri MA, Portella AK, Silveira PP, Bettiol H, Agranonik M, Silva AA, Goldani MZ.
    Pediatr Res; 2009 Feb; 65(2):215-20. PubMed ID: 19047956
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fetal and neonatal programming: evidence and clinical implications.
    Nesterenko TH, Aly H.
    Am J Perinatol; 2009 Mar; 26(3):191-8. PubMed ID: 19031354
    [Abstract] [Full Text] [Related]

  • 11. Experimental IUGR and later diabetes.
    Martin-Gronert MS, Ozanne SE.
    J Intern Med; 2007 May; 261(5):437-52. PubMed ID: 17444883
    [Abstract] [Full Text] [Related]

  • 12. [Fetal weight at weight as predisposing risk factor for type 2 diabetes in adulthood].
    Hernández Valencia M, Zárate A.
    Ginecol Obstet Mex; 2001 Oct; 69():390-8. PubMed ID: 11816527
    [Abstract] [Full Text] [Related]

  • 13. Offspring metabolomic response to maternal protein restriction in a rat model of intrauterine growth restriction (IUGR).
    Alexandre-Gouabau MC, Courant F, Le Gall G, Moyon T, Darmaun D, Parnet P, Coupé B, Antignac JP.
    J Proteome Res; 2011 Jul 01; 10(7):3292-302. PubMed ID: 21608999
    [Abstract] [Full Text] [Related]

  • 14. Intrauterine growth restriction in a low-income country: Risk factors, adverse perinatal outcomes and correlation with current WHO Multicenter Growth Reference.
    Olusanya BO.
    Early Hum Dev; 2010 Jul 01; 86(7):439-44. PubMed ID: 20576369
    [Abstract] [Full Text] [Related]

  • 15. Programming of the stress response: a fundamental mechanism underlying the long-term effects of the fetal environment?
    Phillips DI.
    J Intern Med; 2007 May 01; 261(5):453-60. PubMed ID: 17444884
    [Abstract] [Full Text] [Related]

  • 16. Study of hypothalamic leptin receptor expression in low-birth-weight piglets and effects of leptin supplementation on neonatal growth and development.
    Attig L, Djiane J, Gertler A, Rampin O, Larcher T, Boukthir S, Anton PM, Madec JY, Gourdou I, Abdennebi-Najar L.
    Am J Physiol Endocrinol Metab; 2008 Nov 01; 295(5):E1117-25. PubMed ID: 18780769
    [Abstract] [Full Text] [Related]

  • 17. [Fetal programming--the intrauterine origin of adult morbidity].
    Haimov-Kochman R.
    Harefuah; 2005 Feb 01; 144(2):97-101, 151, 150. PubMed ID: 16128013
    [Abstract] [Full Text] [Related]

  • 18. Intrauterine growth restriction and developmental programming of the metabolic syndrome: a critical appraisal.
    Neitzke U, Harder T, Plagemann A.
    Microcirculation; 2011 May 01; 18(4):304-11. PubMed ID: 21418379
    [Abstract] [Full Text] [Related]

  • 19. Placental 11beta-HSD2 gene expression at birth is inversely correlated with growth velocity in the first year of life after intrauterine growth restriction.
    Tzschoppe A, Struwe E, Blessing H, Fahlbusch F, Liebhaber G, Dörr HG, Rauh M, Rascher W, Goecke TW, Schild RL, Schleussner E, Scheler C, Hübler A, Dahlem P, Dötsch J.
    Pediatr Res; 2009 Jun 01; 65(6):647-53. PubMed ID: 19218882
    [Abstract] [Full Text] [Related]

  • 20. [Risk factors of cardiovascular disease among newborns with intrauterine growth retardation].
    Jóźwiak-Grabysa D, Grabysa R, Cholewa M.
    Przegl Lek; 2002 Jun 01; 59 Suppl 1():134-6. PubMed ID: 12108062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.